Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma. - Croucher, P; Hijzen, A; Shipman, C; Perry, M; Lippitt, J; Green, J; Van Camp, B; Vanderkerken, K (2001)